C57BL/6NCya-Alyrefem1flox/Cya
Common Name
Alyref-flox
Product ID
S-CKO-06045
Backgroud
C57BL/6NCya
Strain ID
CKOCMP-21681-Alyref-B6N-VA
When using this mouse strain in a publication, please cite “Alyref-flox Mouse (Catalog S-CKO-06045) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Alyref-flox
Strain ID
CKOCMP-21681-Alyref-B6N-VA
Gene Name
Product ID
S-CKO-06045
Gene Alias
Aly, Ref1, Tho4, Thoc4, Ref1-I, Refbp1
Background
C57BL/6NCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 11
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000026125
NCBI RefSeq
NM_011568
Target Region
Exon 3
Size of Effective Region
~0.8 kb
Overview of Gene Research
ALYREF, also known as Aly/REF export factor, is an RNA-binding protein. It plays key roles in mRNA export, pre-mRNA processing and mRNA stability regulation. It is associated with the 5-methylcytosine (m5C) modification pathway in mRNA metabolism, which is crucial for various biological processes [2,3].
In cancer research, ALYREF has been found to have significant impacts. In bladder cancer, ALYREF stabilizes PKM2 mRNA by binding to its m5C sites in 3'-untranslated regions, promoting cell proliferation via PKM2-mediated glycolysis. High ALYREF expression predicts poor survival in bladder cancer patients, and hypoxia-inducible factor-1alpha (HIF-1α) can up-regulate PKM2 expression indirectly through ALYREF activation [1].
In urothelial bladder cancer, ALYREF enhances cell proliferation and invasion in an m5C-dependent manner, by specifically binding to hypermethylated m5C sites in RABL6 and TK1 mRNA, promoting their splicing and stabilization. High co-expression of ALYREF/RABL6/TK1 axis is associated with poor overall survival [5].
In non-small cell lung cancer, LINC02159 binds to ALYREF to enhance the stability of YAP1 mRNA via m5C modification, promoting cancer progression [4].
In colorectal cancer, ALYREF forms a complex with ELAVL1 to promote m5C recognition and nuclear export of RPS6KB2 and RPTOR mRNAs, supporting cancer growth and migration, and high ALYREF protein expression predicts poor prognosis [6].
In nasopharyngeal carcinoma, ALYREF up-regulates NOTCH1 expression by enhancing its RNA stability in an m5C-modification-dependent manner, promoting cancer metastasis [7].
In breast cancer, high ALYREF expression is associated with poor prognosis, and ALYREF promotes cancer cell viability and decreases apoptosis by regulating EZH2 [8].
In conclusion, ALYREF is essential for mRNA-related regulatory processes. Through gene-knockout or conditional-knockout mouse models and in vivo studies in cancer research, ALYREF has been shown to play important roles in various cancer-related biological processes such as cell proliferation, invasion, and metastasis. Understanding ALYREF's functions provides potential therapeutic targets for multiple cancers.
References：
1. Wang, Jing-Zi, Zhu, Wei, Han, Jie, Wei, Ji-Fu, Yang, Haiwei. 2021. The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer. In Cancer communications (London, England), 41, 560-575. doi:10.1002/cac2.12158. https://pubmed.ncbi.nlm.nih.gov/33991457/
2. Yang, Xin, Yang, Ying, Sun, Bao-Fa, Sun, Ying-Pu, Yang, Yun-Gui. 2017. 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m5C reader. In Cell research, 27, 606-625. doi:10.1038/cr.2017.55. https://pubmed.ncbi.nlm.nih.gov/28418038/
3. Zhao, Yan, Xing, Cheng, Peng, Hongling. 2023. ALYREF (Aly/REF export factor): A potential biomarker for predicting cancer occurrence and therapeutic efficacy. In Life sciences, 338, 122372. doi:10.1016/j.lfs.2023.122372. https://pubmed.ncbi.nlm.nih.gov/38135116/
4. Yang, Qiurong, Wang, Maoye, Xu, Jing, Gu, Jianmei, Zhang, Xu. 2023. LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling. In Molecular cancer, 22, 122. doi:10.1186/s12943-023-01814-x. https://pubmed.ncbi.nlm.nih.gov/37537569/
5. Wang, Ning, Chen, Ri-Xin, Deng, Min-Hua, Liu, Zhuo-Wei, Zhou, Fang-Jian. 2023. m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization. In Cell death & disease, 14, 139. doi:10.1038/s41419-023-05661-y. https://pubmed.ncbi.nlm.nih.gov/36806253/
6. Zhong, Longhua, Wu, Jingxun, Zhou, Bingqian, Ye, Feng, Lin, Xiaoting. 2024. ALYREF recruits ELAVL1 to promote colorectal tumorigenesis via facilitating RNA m5C recognition and nuclear export. In NPJ precision oncology, 8, 243. doi:10.1038/s41698-024-00737-0. https://pubmed.ncbi.nlm.nih.gov/39455812/
7. Jin, Yanan, Yao, Jijin, Fu, Jianchang, Xia, Tianliang, Xia, Liangping. 2024. ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNA. In Cell death & disease, 15, 578. doi:10.1038/s41419-024-06959-1. https://pubmed.ncbi.nlm.nih.gov/39117671/
8. Jeong, Su-Jin, Oh, Ji Hoon, Cho, Je-Yoel. 2024. ALYREF enhances breast cancer progression by regulating EZH2. In Heliyon, 10, e37749. doi:10.1016/j.heliyon.2024.e37749. https://pubmed.ncbi.nlm.nih.gov/39386827/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.